Jeff Yass’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Jeff Yass’s Portfolio CBMG Stock Details CBMG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-78,000	Closed	-$1.43M	–	13226
2020 Q4	$1.43M	Buy	78,000 +24,700	+46%	+$450K	﹤0.01%	5843
2020 Q3	$978K	Buy	+53,300	New	+$896K	﹤0.01%	6170
2018 Q4	–	Sell	-16,700	Closed	-$303K	–	10389
2018 Q3	$303K	Buy	+16,700	New	+$342K	﹤0.01%	7472
2018 Q2	–	Sell	-11,900	Closed	-$209K	–	10761
2018 Q1	$209K	Buy	+11,900	New	+$218K	﹤0.01%	8257

Jeff Yass's CBMG Position: Q1 2021 in Review

Jeff Yass sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 83,121 shares — an estimated $1.53M sold.

Jeff Yass first reported a position in CBMG in Q1 2015 and held it in 6 quarters. The position peaked at $1.53M in Q4 2020. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.

Jeff Yass reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
Jeff Yass sold 83,121 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $1.53M.
Jeff Yass first reported a position in Cellular Biomedicine Group, Inc. in Q1 2015 and held it in 6 quarters.
Jeff Yass's Cellular Biomedicine Group, Inc. position peaked at $1.53M in Q4 2020.
0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.

Based on Susquehanna International Group's 13F filing for Q1 2021, filed 17 May 2021.